200 related articles for article (PubMed ID: 9568787)
1. Prostate-specific antigen production in the female breast: association with progesterone.
Sauter ER; Babb J; Daly M; Engstrom PF; Ehya H; Malick J; Diamandis E
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):315-20. PubMed ID: 9568787
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers associated with breast cancer are associated with obesity.
Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
[TBL] [Abstract][Full Text] [Related]
3. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women.
Petrakis NL; Barnes S; King EB; Lowenstein J; Wiencke J; Lee MM; Miike R; Kirk M; Coward L
Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):785-94. PubMed ID: 8896889
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk.
Sauter ER; Daly M; Linahan K; Ehya H; Engstrom PF; Bonney G; Ross EA; Yu H; Diamandis E
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):967-70. PubMed ID: 8959318
[TBL] [Abstract][Full Text] [Related]
5. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size.
Sauter ER; Ehya H; Babb J; Diamandis E; Daly M; Klein-Szanto A; Sigurdson E; Hoffman J; Malick J; Engstrom PF
Br J Cancer; 1999 Dec; 81(7):1222-7. PubMed ID: 10584885
[TBL] [Abstract][Full Text] [Related]
6. Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer.
Sauter ER; Garofalo C; Hewett J; Hewett JE; Morelli C; Surmacz E
Horm Metab Res; 2004 May; 36(5):336-40. PubMed ID: 15156414
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins.
Gann PH; Geiger AS; Helenowski IB; Vonesh EF; Chatterton RT
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):39-44. PubMed ID: 16434584
[TBL] [Abstract][Full Text] [Related]
8. Nipple aspirate fluid color is associated with breast cancer.
Sauter ER; Winn JN; Dale PS; Wagner-Mann C
Cancer Detect Prev; 2006; 30(4):322-8. PubMed ID: 16963197
[TBL] [Abstract][Full Text] [Related]
9. Prospective multicenter trial to determine the feasibility of collection and predictive ability of breast fluid analysis in postmenopausal women receiving SERMs.
Sauter ER; Ganz PA; Ehya H; Hewett JE; Schlatter L; Kliethermes B; Daly MB
Breast; 2007 Oct; 16(5):489-94. PubMed ID: 17482465
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen (PSA) in women.
Yu H; Berkel H
J La State Med Soc; 1999 Apr; 151(4):209-13. PubMed ID: 10234897
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer.
Sauter ER; Klein G; Wagner-Mann C; Diamandis EP
Cancer Detect Prev; 2004; 28(1):27-31. PubMed ID: 15041074
[TBL] [Abstract][Full Text] [Related]
12. Variation in estradiol, estradiol precursors, and estrogen-related products in nipple aspirate fluid from normal premenopausal women.
Chatterton RT; Geiger AS; Khan SA; Helenowski IB; Jovanovic BD; Gann PH
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):928-35. PubMed ID: 15184248
[TBL] [Abstract][Full Text] [Related]
13. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.
Higgins SA; Matloff ET; Rimm DL; Dziura J; Haffty BG; King BL
Breast Cancer Res; 2005; 7(6):R1017-22. PubMed ID: 16280052
[TBL] [Abstract][Full Text] [Related]
14. Nipple aspirate fluid cytology in breast carcinoma.
Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen in nipple aspiration fluid: menstrual cycle variability and correlation with serum prostate-specific antigen.
Mitchell G; Sibley PE; Wilson AP; Sauter E; A'Hern R; Eeles RA
Tumour Biol; 2002; 23(5):287-97. PubMed ID: 12595745
[TBL] [Abstract][Full Text] [Related]
16. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population.
Tice JA; Miike R; Adduci K; Petrakis NL; King E; Wrensch MR
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):324-8. PubMed ID: 15734953
[TBL] [Abstract][Full Text] [Related]
17. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
18. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.
Buehring GC; Letscher A; McGirr KM; Khandhar S; Che LH; Nguyen CT; Hackett AJ
Breast Cancer Res Treat; 2006 Jul; 98(1):63-70. PubMed ID: 16685591
[TBL] [Abstract][Full Text] [Related]
19. Association of abnormal nipple aspirate cytology and mammographic pattern and density.
Lee MM; Petrakis NL; Wrensch MR; King EB; Miike R; Sickles E
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):33-6. PubMed ID: 8118383
[TBL] [Abstract][Full Text] [Related]
20. Identification of a chemoprevention cohort from a population of women at high risk for breast cancer.
Fabian CJ; Kamel S; Zalles C; Kimler BF
J Cell Biochem Suppl; 1996; 25():112-22. PubMed ID: 9027607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
